Skip to content

Effect of Ayurvedic De-addiction Therapy (ADT) on smoking cessation

An exploratory clinical trial assessing the efficacy of ADT (Ayurvedic De-addiction Therapy) on smoking cessation

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052364
Enrollment
30
Registered
2023-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F172- Nicotine dependence

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age:21-60years 2.Patients arha for sadyo vamana and kosta shodhana 3.Patients giving consent for participating in the study

Exclusion criteria

Exclusion criteria: 1.Those having associated Alcohol addiction / Substance abuse 2.Any serious Cardiac Diseases like Supraventricular tachycardia, Arrhythmias, CAD with obstruction > 60% in two major vessels 3.Uncontrolled Hypertension( >160/100 mmHg) /Diabetes 4.Status asthmaticus and COPD 5.Pregnant and lactating women 6.Any significant psychiatric illness or mood disorder 7.HAD scale (A + D >= 19, the day of the selection and inclusion) 8.Subject smoking cigars or pipes exclusively 9.Subject taking any antismoking medication and/ or Nicotine Replacement Therapy (NRT) in the previous month. 10.Those who are anarha for sadyo vamana and kosta shodhana 11.Those who are taking any other medications interfering with the treatment protocol 12.Those who are allergic to the medications

Design outcomes

Primary

MeasureTime frame
1.Number of Days With Self-report of No Smoking and Breath Carbon Monoxide of less than 6 PPM During Quit-attempt Weeks 2.4-week prolonged abstinence from smoking cigarettes Timepoint: Baseline, after 7 days, after every 15 days for the next 90 days

Secondary

MeasureTime frame
1.7-day tobacco Point Prevalence Abstinence (PPA) 2.Number of adverse events 3.Vital signs measures 4.Cue- Reactivity Visual Analogue Scale for Craving Timepoint: Baseline, after 7 days, after every 15 days for the next 90 days

Countries

India

Contacts

Public ContactDr Divya Kajaria

All India Institute of Ayurveda

divyakajaria@gmail.com8826167515

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026